Factor IX activity measurement of recombinant FIX Fc fusion protein eftrenonacog alfa with one-stage clotting and chromogenic substrate assay

被引：0
|
作者：
Prudkova, Marie [1 ,2 ,3 ,4 ]
Chytra, Dagmar [1 ,4 ]
Smejkal, Petr [1 ,4 ]
Zavrelova, Jirina [1 ,4 ]
Kovarikova, Jana [1 ,4 ]
Penka, Miroslav [1 ,2 ,3 ]
Bulikova, Alena [1 ,2 ,3 ]
机构：
[1] Univ Hosp Brno, Dept Clin Hematol, Brno, Czech Republic
[2] Univ Hosp Brno, Dept Internal Med Hematol & Oncol, Brno, Czech Republic
[3] Masaryk Univ Brno, Fac Med, Brno, Czech Republic
[4] Masaryk Univ Brno, Dept Lab Methods, Fac Med, Brno, Czech Republic
来源：
HAEMOPHILIA | 2024年 / 30卷
关键词：
chromogenic substrate assay; one-stage clotting assay; recombinant factor IX Fc fusion protein;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PP-074 (16
引用
收藏
页码：87 / 87
页数：1
相关论文
共 50 条
  • [21] Assessment of clotting activity of recombinant fix FC fusion protein in European hemophilia treatment centers
    Willemze, A.
    Sadeghi-Khomami, A.
    Sorskog, L.
    Wiken, M.
    Lethagen, S.
    HAEMOPHILIA, 2018, 24 : 55 - 55
  • [22] Assessment of clotting activity of recombinant FIX-Fc fusion protein in French haemostasis laboratories
    Pouplard, C.
    Ternisien, C.
    Sadeghi-Khomami, A.
    Martinez, C.
    HAEMOPHILIA, 2019, 25 : 65 - 65
  • [23] Potency estimates for recombinant Factor IX in the one-stage clotting assay are influenced by more than just choice of APTT reagent
    Wilmot, H.
    Gray, E.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2016, 14 : 61 - 62
  • [24] Comparison of RIXUBIS with another recombinant FIX product for behavior in chromogenic and one-stage clotting assays using different APTT reagents
    Gritsch, H.
    Romeder-Finger, S.
    Scheiflinger, F.
    Turecek, P. L.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 : 40 - 40
  • [25] Overestimation of N-glycoPEGylated factor IX activity in a one-stage factor IX clotting assay owing to silica-mediated premature conversion to activated factor IX
    Rosen, P.
    Rosen, S.
    Ezban, M.
    Persson, E.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2016, 14 (07) : 1420 - 1427
  • [26] FACTOR-VIII ACTIVITY AS MEASURED BY AN AMIDOLYTIC ASSAY COMPARED WITH A ONE-STAGE CLOTTING ASSAY
    TRIPODI, A
    MANNUCCI, PM
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1986, 86 (03) : 341 - 344
  • [27] FACTOR-VIII ACTIVITY AS MEASURED BY AN AMIDOLYTIC ASSAY COMPARED WITH A ONE-STAGE CLOTTING ASSAY
    TRIPODI, A
    MANNUCCI, PM
    RICERCA IN CLINICA E IN LABORATORIO, 1986, 16 (01): : 132 - 133
  • [28] Measurement of factor VIII activity of efraloctocog alfa with commercially available one-stage clotting and chromogenic assays: Results from the Belgian national External Quality Assessment Scheme
    Van Blerk, Marjan
    Chatelain, Bernard
    Devreese, Katrien
    Jacquemin, Marc
    Jochmans, Kristin
    Mullier, Francois
    Soumali, Mohamed R.
    Broeders, Sylvia
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2019, 41 (01) : E20 - E22
  • [29] One-stage clotting versus chromogenic assays for assessing recombinant factor VIII: two faces of a haemostasis coin
    Lippi, Giuseppe
    Franchini, Massimo
    Favaloro, Emmanuel. J.
    BLOOD COAGULATION & FIBRINOLYSIS, 2009, 20 (01) : 1 - 3
  • [30] Chromogenic vs. one-stage measurement of residual factor VIII activity in the Bethesda assay: A methodological comparison.
    Macartney, AR
    King, E
    Moore, G
    Alhaq, A
    Savidge, GF
    BLOOD, 2001, 98 (11) : 82B - 82B
12345